see risk appear contribut come light
compound impact cyclic deceler legaci busi believ stimul
acquir organ growth materi improv margin nt mutual exclus given
cost requir shift view given central stori put multipl
still risk pt
margin declin coincid recent deal go organ
acquisit portfolio transform improv fortiv busi
heart stori agre strategi broadli
often challeng achiev success particularli move higher price
acquisit instanc like landauer asp transact team task
materi improv organ growth margin order achiev return
object typic year believ spend requir stimul
growth pressur nt margin perform begun see evid core
margin pressur profession instrument sale
target deal enter organ present despit posit organ growth
 potenti alarm given critic overal strategi
sinc isc went core landauer seen straight quarter
core margin declin nearli averag organ growth segment declin
acceler quarter much larger gordian/accru price vs isc/
landauer set go core asp next april dynam
like gain meaning focu revers near futur estim
alreadi street midpoint guid factor modest core
expans recent perform suggest might aggress
deal math achiev target challeng gordian/accruent/asp risk
compound core margin challeng seen initi expect revis lower new
deal asp initi seen accret year lsd/msd growth
expect low end rang appear target estim
even hit low end target ebitda margin increas
first month manag expect achiev year asp
assum happen busi grow per year period
ebitda margin would essenti doubl increment
revenu base would need drop ebitda alreadi assum
synergi target achiev imposs certainli easi either
gordian/accru impli guidanc contribut
past quarter achiev manag target first
month last go core would come higher end
rang would requir estim ebitda step level
believ closer bottom end rang reason would
put year initi guid achiev assum hsd revenu
growth rate estim ebitda margin would move
increment ebitda would gener increment revenu even
assum similar synergi level asp well increment revenu would
drop ebitda
pleas see page report import disclosur
made signific portfolio move past two year divest
cyclic specialti busi acquir asset across healthcar
asset manag sector higher recur revenu base integr move
forefront return target take precis achiev seen evid suggest
profit acquir busi potenti come light could pressur
multipl near-term risk cyclic legaci busi serv chines
semiconductor us auto market
integr new healthcar digit
averag annual rang
like howev model near-term
deploy like modest given pace
expans bp
faster anticip histor
emv implement pump
faster implement adopt
anoth signific slowdown
industri activ around world
failur identifi integr new
compani portfolio margin
target met
return sustain growth
slower expect emv
implement fuel pump
fortiv corpor creat result juli spin-off
new home danah test measur segment industri technolog segment
dhr retail/commerci petroleum platform compani oper two segment
six platform total key busi profession instrument
segment provid instrument measur monitor physic paramet sens
technolog medic steril industri technolog segment includ
transport solut compon softwar distribut manufactur
transport market global busi play nich market
lead brand sector similar oper model expect
act market consolid strong activ global employe
guid fortiv busi system fb deriv predecessor
alreadi see adjust rel multipl vs high qualiti compound could
seen stark contrast rel trade momentum result
year lead last quarter core margin perform move
materi lower outperform industri sector
roughli even vs sinc share under-perform
rel multipl compress similar amount despit
move share still trade roughli par see neg
revis estim shift percept around discount could play
note asp gordian/accru expect add adjust
earn year cost anoth deal similar size impact
like feasibl next month exit net leverag
current multipl hold would impli upsid risk howev one turn
trim ev/ebitda multipl could neutral impact expect
last quarter weve seen sign acceler declin core margin
perform profession instrument coincid two fairli sizeabl
deal isc landauer nearli deploy total move core perform
year ownership dont data necessari determin
exact caus note occur despit consist posit organ growth
segment
compani report cowen compani
subsequ isc laundauer transact among other ad larger
recent asp close april compound neg core
margin trend discuss past quarter saw meaning neg shift
impli profit newli acquir revenu yet reach core
asp close april critic long-term bullish argument
see improv metric dont doubt ftv abil integr
busi believ drive growth materi improv margin newli
acquir busi contemporan challeng spend stimul top
line come cost case like landauer asp organ growth prior
leadership weak certain instanc under-perform
underli market given improv margin need hit return target
explor detail next section possibl invest need
creat headwind initi guidanc
instrument organ growth margin trendsorgan growth y/i margin chang y/i isc goe corelandau goe core cowen
figur materi neg shift newli acquir busi profit observ last quarter
compani report cowen compani
challeng math hit deal target
see risk near-term accret target highlight steep margin
path hit long-term object compound fact recent
margin appear under-perform
manag current expect year adjust ep accret
note accret span busi goe
core assum guid achiev impli major step
manag go achiev initi year target busi would need
gener nearli twice ep vs current guid estim
would requir nearli ebitda margin step vs
instrument contribut profit trendsm revenu mm impli ebit mm pre amort addback impli adjust oper incom mm post amort addback impli ebit margin pre amort addback impli adj oper incom margin post amort addback cowen
figur nearli margin step vs requir gordian/accru
contribut achiev year accret
compani report cowen compani
path similarli steep long-term goal case averag
year assum revenu compound-annual-growth-rate throughout period gordian
current grow bit faster accruent bit slower estim
ebitda margin would need move top line
assumpt impli increment revenu gener year
howev order achiev requir ebitda margin revenu would
translat increment ebitda even assum synergi
nearli initi sale would still requir increment revenu
gener drop ebitda line seem like challeng base case
figur increment revenu gener need drop ebitda achiev return
compani report cowen compani
asp deal announc june close april upon
announc initi accret estim year rang
asp like grow slightli least initi steril market msd
growth rate sinc commentari gravit toward low end year
accret rang top line expect appear lsd rang
period greater one year
manag current guid impact
assum roughli linear slope estim hit year target requir
ebitda margin improv next month
gordian/accru path year revenu op ebitda ebita financ net return increment revenu cowen
figur estim year margin improv need hit accret goal
compani report cowen compani
synergi expect rang year period assum
year would impli year revenu base
long-term target case year requir similar ramp
gordian/asp assum revenu growth move
estim ebitda margin need move despit work
need stimul top line compar vs first full calendar
year estim increment revenu need translat
nearli increment ebitda addit synergi
assum achiev nearli requir drop
asp estim path year ep op ebitda ebita net cowen
figur year target requir roughli doubl margin revenu drop
assum synergi achiev
compani report cowen compani
perform valuat
share under-perform high qualiti peer sinc result came
buysid expect includ guid street despit pullback
howev share still trade larg line ev/ebitda
modestli ftv histor averag increment concern
regard materi discount could argu target still impli
healthi ev/ebitda multipl
asp estim path year revenu op ebitda ebita net return note repres month increment revenu cowen
figur valuat come still dhr/ame could discount
thomson reuter cowen compani
compani report cowen compani
consolid incom statement sale sale margin gener administr charg margin expens incom incom tax tax rate effec tax rate convert prefer stock cumul incom continu discontinu oper net incom incom fortiv common averag basic share averag dilut share estim end dilut averag dilut share average common stock common equival basic ep continu dilut ep continu pay-out adjust pay-out metricsreport oper divestitur restructur oper adjust oper margin increment margin intang oper incom intang amort adjust oper margin increment margin adjust ebitda margin increment margin net incom common convert prefer restructur deal relat amort tax provision tcja separ net dilut prefer assum convert share restructur deal relat amort tax estim provision tcja separ dilut cowen
compani report cowen compani
multipl valuat analysi equiti intang addback epsforward convert cowen
util multipl analysi discount cash flow dcf analysi valu compani
coverag employ ev/ebitda price-to-earnings multipl analysi look histor
valuat multipl typic averag well current histor
multipl competitor repres compani evalu subject compani
independ term comp group certain instanc may look current/
recent transact multipl evalu subject compani util dcf analysi
includ sensit tabl discount termin growth rate
gener declin industri product index coupl global decreas
autom spend percentag total capital-expenditure could neg impact sector
impli industri growth rate
sustain pressur emerg market especi countri lower labor wage could
caus delay autom implement sever sector includ gener industri
automot logist medic aerospac factori upgrad delay
upsid risk price target includ
model margin expand bp annual margin expans closer
manag target could increas pt
faster anticip emv implement fuel pump could make gvr revenu
integr newli acquir busi progress ahead schedul
